About Cytely
Cytely is a company based in Lund (Sweden) founded in 2022 by Johannes Ahnlide and Philip Nordenfelt. Cytely has raised $3.48 million across 2 funding rounds from investors including SmiLe Incubator, Icebreaker.vc and Ugly Duckling Ventures. Cytely offers products and services including Cytely Platform and CYTELY CLI. Cytely operates in a competitive market with competitors including Hooke Bio, Alpenglow Biosciences, Noul, SpotLab and ACUITYnano, among others.
- Headquarter Lund, Sweden
- Founders Johannes Ahnlide, Philip Nordenfelt
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cytely Ab
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.48 M (USD)
in 2 rounds
-
Latest Funding Round
$3.48 M (USD), Series A
Oct 24, 2025
-
Investors
SmiLe Incubator
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cytely
Cytely offers a comprehensive portfolio of products and services, including Cytely Platform and CYTELY CLI.
Automates data collection and analysis for scientific microscopy research.
Enables high-fidelity data processing in microscopy applications.
Funding Insights of Cytely
Cytely has successfully raised a total of $3.48M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $3.48 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cytely
Cytely has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include SmiLe Incubator, Icebreaker.vc and Ugly Duckling Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed and early-stage tech investments are targeted in Finland.
|
Locked | Locked | Locked | |
|
Startup accelerator and incubator
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Cytely
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cytely
Investment portfolio details for Cytely
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cytely
Detailed financials for Cytely
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cytely Comparisons
Peer comparison for Cytely
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cytely
Cytely operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hooke Bio, Alpenglow Biosciences, Noul, SpotLab and ACUITYnano, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Solutions for 3D microtissue analysis are provided by Hooke Bio.
|
|
| Locked | Locked | Locked |
3D visualization software for tissue image analysis is provided.
|
|
| Locked | Locked | Locked |
An AI-based digital microscope platform is used for blood analysis.
|
|
| Locked | Locked | Locked |
AI-powered solutions for biopharma research and diagnostics are provided.
|
|
| Locked | Locked | Locked |
Provides portfolio of biotechnological research
|
|
| Locked | Locked | Locked |
Develops AI-powered solutions for biological research and imaging.
|
Detailed competitors of Cytely
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cytely
Complete news archive for Cytely
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cytely
Cytely was founded in 2022 and raised its 1st funding round 2 years after it was founded.
Cytely is headquartered in Lund, Sweden.
Philip Nordenfelt is the current CEO of Cytely. They have also founded this company.
Cytely is a funded company, having raised a total of $3.48M across 2 funding rounds to date.
Cytely was founded in 2022 in Lund, Sweden, within the biomedical research sector. A hardware-agnostic platform is offered that integrates with motorized microscopes to enable qualitative analysis of individual cells alongside high-resolution imaging of sample populations. The entire microscopy workflow, from image acquisition to real-time analysis, is automated through AI and machine learning technologies. Operations focus on enhancing research efficiency in cellular studies.
Cytely's top competitors include Alpenglow Biosciences, Hooke Bio and Noul.
Cytely offers Cytely Platform and CYTELY CLI.
Cytely has 3 investors. Key investors include SmiLe Incubator, Icebreaker.vc, and Ugly Duckling Ventures.